I'll answer in English, if you don't mind.
The fact that the act is not able to move forward because of the judicial challenge means that the regulations that the act requires to be set in place are not in place. Currently, the act that should apply to the derivation of human embryonic stem cells or any use of human reproductive material would require a licence through the regulations of the act. The regulations are not in place, so there in fact is no means, for the act, of actually looking over stem cell research and the use of human reproductive material.
It's a big issue, not just for stem cell research but for human reproductive technologies. IVF programs are supposed to be regulated under the act, and they are currently not because the act is in limbo and the regulations are not in place.
So it has actually a broad impact on the use of human reproductive materials.